Chronic kidney disease alters vascular smooth muscle cell phenotype

Frontiers in Bioscience - Landmark

Volumn 20, Issue 4, 2015, Pages 784-795

  Monroy, M Alexandra ^a   Fang, Jianhua ^a   Li, Shan ^a   Ferrer, Lucas ^a   Birkenbach, Mark P ^a   Lee, Iris J ^a   Wang, Hong ^a   Yang, Xiao Feng ^a   Choi, Eric T ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arteriovenous fistula; Arteriovenous grafts; Chronic kidney disease; Hyperplasia; Uremia; Vascular access dysfunction; Vascular smooth muscle cells

Indexed keywords

BIOLOGICAL MARKER; STAUROSPORINE;

APOPTOSIS; BLOOD; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY FAILURE; DRUG EFFECTS; HUMAN; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; UREMIA; VASCULAR SMOOTH MUSCLE;

APOPTOSIS; BIOMARKERS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; KIDNEY FAILURE, CHRONIC; MUSCLE, SMOOTH, VASCULAR; REAL-TIME POLYMERASE CHAIN REACTION; STAUROSPORINE; UREMIA; VASCULAR ACCESS DEVICES;

EID: 84918833716     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4337     Document Type: Article

References (29)

1. C.-y. Hsu, E. Vittinghoff, F. Lin and M. G. Shlipak: The Incidence of End-Stage Renal Disease Is Increasing Faster than the Prevalence of Chronic Renal Insufficiency. Annals of Internal Medicine, 141(2), 95-101 (2004) DOI: 10.7326/0003-4819-141-2-200407200-00007
2. H. Feldman, S. Kobrin and A. Wasserstein: Hemodialysis vascular access morbidity. Journal of the American Society of Nephrology, 7(4), 523-535 (1996)
3. H. Lee, B. Manns, K. Taub, W. A. Ghali, S. Dean, D. Johnson and C. Donaldson: Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases, 40(3), 611-622 (2002) DOI: 10.1.053/ajkd.2002.3.4924
4. T. Lee and P. Roy-Chaudhury: Advances and New Frontiers in the Pathophysiology of Venous Neointimal Hyperplasia and Dialysis Access Stenosis. Advances in Chronic Kidney Disease, 16(5), 329-338 (2009) DOI: 10.1.053/j.ackd.2009.0.6.0.09
5. J. Tordoir, B. Canaud, P. Haage, K. Konner, A. Basci, D. Fouque, J. Kooman, A. Martin-Malo, L. Pedrini, F. Pizzarelli, J. Tattersall, M. Vennegoor, C. Wanner, P. ter Wee and R. Vanholder: EBPG on Vascular Access. Nephrology Dialysis Transplantation, 22(suppl 2), ii88-ii117 (2007) DOI: 10.1.093/ndt/gfm021
6. A. Biuckians, E. C. Scott, G. H. Meier, J. M. Panneton and M. H. Glickman: The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. Journal of Vascular Surgery, 47(2), 415-421 (2008) DOI: 10.1.016/j.jvs.2007.1.0.0.41
7. M. A. Wali, R. A. Eid, M. Dewan and M. A. Al-Homrany: Intimal Changes in the Cephalic Vein of Renal Failure Patients before Arterio-Venous Fistula (AVF) Construction. Jornal of Smooth Muscle Research, 39(4), 95-105 (2003) DOI: 10.1540/jsmr.39.95
8. Y. M. Ku, Y. O. Kim, J. I. Kim, Y. J. Choi, S. A. Yoon, Y. S. Kim, S. W. Song, C. W. Yang, Y. S. Kim, Y. S. Chang and B. K. Bang: Ultrasonographic measurement of intima-media thickness of radial artery in pre-dialysis uraemic patients: comparison with histological examination. Nephrology Dialysis Transplantation, 21(3), 715-720 (2006) DOI: 10.1.093/ndt/gfi214
9. T. Lee, V. Chauhan, M. Krishnamoorthy, Y. Wang, L. Arend, M. J. Mistry, M. El-Khatib, R. Banerjee, R. Munda and P. Roy-Chaudhury: Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrology Dialysis Transplantation, 26, 2264-2270 (2011) DOI: 10.1093/ndt/gfq733
10. S. Langer, M. Kokozidou, C. Heiss, J. Kranz, T. Kessler, N. Paulus, T. Kruger, M. J. Jacobs, C. Lente and T. A. Koeppel: Chronic kidney disease aggravates arteriovenous fistula damage in rats. Kidney Int, 78(12), 1312-1321 (2010) DOI: 10.1038/ki.2010.353
11. T. Kokubo, N. Ishikawa, H. Uchida, S. E. Chasnoff, X. Xie, S. Mathew, K. A. Hruska and E. T. Choi: CKD Accelerates Development of Neointimal Hyperplasia in Arteriovenous Fistulas. Journal of the American Society of Nephrology, 20(6), 1236-1245 (2009) DOI: 10.1.681/asn.2007121312
12. M. J. Sarnak and R. N. Foley: Cardiovascular Mortality in the General Population Versus Dialysis: A Glass Half Full or Empty? American Journal of Kidney Diseases, 58(1), 4-6 (2011) DOI: 10.1.053/j.ajkd.2011.0.4.0.04
13. G. K. Owens: Regulation of differentiation of vascular smooth muscle cells. Physiological Reviews, 75(3), 487-517 (1995)
14. C. P. Regan, P. J. Adam, C. S. Madsen and G. K. Owens: Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. The Journal of Clinical Investigation, 106(9), 1139-1147 (2000) DOI: 10.1172/JCI10522
15. G. K. Owens, M. S. Kumar and B. R. Wamhoff: Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease. Physiological Reviews, 84(3), 767-801 (2004) DOI: 10.1.152/physrev.00041.2.003
16. A. Slupianek, S. Yerrum, F. F. Safadi and M. A. Monroy: The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells. Journal of Cellular Physiology, 224(2), 369-375 (2010) DOI: 10.1.002/jcp.22132
17. K. Gabunia, S. Jain, R. N. England and M. V. Autieri: Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. American Journal of Physiology - Cell Physiology, 300(4), C896-C906 (2011) DOI: 10.1.152/ajpcell.00439.2.010
18. T. Kouzarides: Chromatin modifications and their function. Cell, 128, 693-705 (2007) DOI: 10.1016/j.cell.2007.02.005
19. G. S. Hotamisligil: Endoplasmic reticulum stress and atherosclerosis. Nat Med, 16(4), 396-399 (2010) DOI: 10.1038/nm0410-396
20. S. M. Schwartz: Smooth muscle migration in vascular development and pathogenesis. Transplant Immunology, 5(4), 255-260 (1997) DOI: http://dx.doi.org/10.1.016/S0966-3274(97)80005-6
21. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch and C.-y. Hsu: Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. New England Journal of Medicine, 351(13), 1296-1305 (2004) DOI: doi:10.1.056/NEJMoa041031
22. P. Brunet, B. Gondouin, A. Duval-Sabatier, L. Dou, C. Cerini, F. Dignat-George, N. Jourde-Chiche, A. Argiles and S. Burtey: Does Uremia Cause Vascular Dysfunction. Kidney and Blood Pressure Research, 34(4), 284-290 (2011) DOI: 10.1159/000327131
23. Z.-P. Liu, Z. Wang, H. Yanagisawa and E. N. Olson: Phenotypic Modulation of Smooth Muscle Cells through Interaction of Foxo4 and Myocardin. Developmental Cell, 9(2), 261-270 (2005) DOI: http://dx.doi.org/10.1.016/j.devcel.2005.0.5.0.17
24. T. Jenuwein and C. D. Allis: Translating the Histone Code. Science, 293(5532), 1074-1080 (2001) DOI: 10.1.126/science.1063127
25. M. R. Alexander, M. Murgai, C. W. Moehle and G. K. Owens: Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms. Physiological Genomics, 44(7), 417-429 (2012) DOI: 10.1.152/phy siolgenomics.00160.2.011
26. M. G. Davies and H. P.O: Pathobiology of intimal hyperplasia. Br. J Surg, 81, 1254-1269 (1994)
27. E. Trécherel, C. Godin, C. Louandre, J. Benchitrit, S. Poirot, J.-C. Mazière, Z. A. Massy and A. Galmiche: Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditions. Biochemical and Biophysical Research Communications, 417(1), 479-483 (2012) DOI: http://dx.doi.org/10.1.016/j.bbrc.2011.1.1.1.44
28. M. Serradell, M. Díaz Ricart, A. Cases, J. Petriz, A. Ordinas and G. Escolar: Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture. Nephrology Dialysis Transplantation, 18(6), 1079-1085 (2003) DOI: 10.1.093/ndt/gfg161
29. M. C. R. a. P. Roy-Chaudhury: Vascular access in haemodialysis: strengthening the Achilles' heel. Nat. Rev. Nephrol., 9, 348-357 (2013)